The store will not work correctly when cookies are disabled.
2-(2,4-dioxo-1-phenyl-pyrimidin-5-yl)-4,5,6,7-tetrafluoro-isoindoline-1,3-dione
ID: ALA4647682
PubChem CID: 156020000
Max Phase: Preclinical
Molecular Formula: C18H7F4N3O4
Molecular Weight: 405.26
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: O=C1c2c(F)c(F)c(F)c(F)c2C(=O)N1c1cn(-c2ccccc2)c(=O)[nH]c1=O
Standard InChI: InChI=1S/C18H7F4N3O4/c19-11-9-10(12(20)14(22)13(11)21)17(28)25(16(9)27)8-6-24(18(29)23-15(8)26)7-4-2-1-3-5-7/h1-6H,(H,23,26,29)
Standard InChI Key: VKGQLXSGSOZFLF-UHFFFAOYSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
2.4111 -11.8401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1244 -11.4256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8339 -11.8395 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8339 -12.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1229 -13.0747 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4111 -12.6662 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.6935 -13.0811 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
3.1229 -13.9002 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
4.6183 -12.9171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1034 -12.2503 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6184 -11.5834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8320 -10.7854 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9290 -12.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3398 -11.5369 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1653 -11.5369 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.5802 -12.2503 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1653 -12.9638 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3398 -12.9638 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9290 -13.6813 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.4059 -12.2503 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.5802 -10.8236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1656 -10.1057 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5796 -9.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4056 -9.3961 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8153 -10.1074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.4068 -10.8236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.8320 -13.7151 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.1244 -10.6000 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.6935 -11.4252 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
5 8 1 0
4 9 1 0
10 9 1 0
11 10 1 0
3 11 1 0
11 12 2 0
13 10 1 0
13 14 2 0
15 14 1 0
16 15 1 0
17 16 1 0
18 17 1 0
13 18 1 0
18 19 2 0
16 20 2 0
21 15 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
9 27 2 0
2 28 1 0
1 29 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 405.26 | Molecular Weight (Monoisotopic): 405.0373 | AlogP: 1.88 | #Rotatable Bonds: 2 |
Polar Surface Area: 92.24 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.43 | CX Basic pKa: ┄ | CX LogP: 2.26 | CX LogD: 2.22 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.31 | Np Likeness Score: -0.82 |